General
Preferred name
METIAMIDE
Synonyms
SK&F 92058 ()
NSC-307755 ()
P&D ID
PD004526
CAS
34839-70-8
Tags
available
drug candidate
Drug indication
Antagonist (to histamine-H2 receptors)
Discovery agent
Drug Status
experimental
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Metiamide was an intermediate compound in the development process which identified the successful anti-ulcer drug . (GtoPdb)
Compound Sets
8
ChEMBL Drugs
CHEMBL275446
DrugBank
DB08805
DrugMAP
DMO7JGS
DrugMatrix
Guide to Pharmacology
1233
Ki Database
Metiamide
MedChem Express Bioactive Compound Library
HY-15540
TargetMol Bioactive Compound Library
T7524
External IDs
26
Properties
(calculated by RDKit )
Molecular Weight
244.08
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
3
Rotatable Bonds
5
Ring Count
1
Aromatic Ring Count
1
cLogP
1.05
TPSA
52.74
Fraction CSP3
0.56
Chiral centers
0.0
Largest ring
5.0
QED
0.53
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Neuroscience
GPCR/G protein
Immunology/Inflammation
Neuronal Signaling
Target
H2 receptor
Histamine Receptor
Source data